They also showed that Knockdown of BC200 significantly suppressed BACE1 levels, increased cell viability and reduced cell apoptosis in AD cells, which can be reversed by BC200 overexpression (Li et al., 2018[21]). Here, BCYRN1 is linked to Alzheimer disease.